Company News for Aug 19, 2025
Shares of Meta Platforms, Inc. META slid 2.3% as the company revealed it plans to price its upcoming display-equipped smart glasses lower than anticipated.
Intel Corporation's INTC shares fell 3.7% after reports that the U.S. government may convert $10.9 billion in Chips Act grants into a 10% equity stake, sparking dilution concerns.
Shares of Electronic Arts Inc. EA fell 3.2% on the communication services sector losing out in the day.
Radical New Technology Could Hand Investors Huge Gains
Quantum Computing is the next technological revolution, and it could be even more advanced than AI.
While some believed the technology was years away, it is already present and moving fast. Large hyperscalers, such as Microsoft, Google, Amazon, Oracle, and even Meta and Tesla, are scrambling to integrate quantum computing into their infrastructure.
Senior Stock Strategist Kevin Cook reveals 7 carefully selected stocks poised to dominate the quantum computing landscape in his report, Beyond AI: The Quantum Leap in Computing Power.
Kevin was among the early experts who recognized NVIDIA's enormous potential back in 2016. Now, he has keyed in on what could be "the next big thing" in quantum computing supremacy. Today, you have a rare chance to position your portfolio at the forefront of this opportunity.
See Top Quantum Stocks Now >>
Want the latest recommendations from Zacks Investment Research? Today, you can download 7 Best Stocks for the Next 30 Days. Click to get this free report
Intel Corporation (INTC): Free Stock Analysis Report
First Solar, Inc. (FSLR): Free Stock Analysis Report
Electronic Arts Inc. (EA): Free Stock Analysis Report
Meta Platforms, Inc. (META): Free Stock Analysis Report
Try Our AI Features
Explore what Daily8 AI can do for you:
Comments
No comments yet...
Related Articles
Cision Canada
an hour ago
- Cision Canada
Canada strengthens global leadership in medical isotope production
Government achieves new milestone in partnership with Bruce Power and First Nation on producing cancer-fighting medical isotopes TIVERTON, ON, Aug. 19, 2025 /CNW/ - The Government of Canada is investing in Canada's nuclear, biomanufacturing and life sciences sectors to strengthen Canada's position as a global leader in nuclear medicine innovation. These investments are bolstering domestic supply chains to ensure Canadians have access to vital diagnostics and therapeutic treatments. Today, the Honourable Tim Hodgson, Minister of Energy and Natural Resources, on behalf of the Honourable Mélanie Joly, Minister of Industry and Minister responsible for Canada Economic Development for Quebec Regions, announced the next phase of an ambitious medical isotope production project at the Bruce Power nuclear plant facility in Tiverton, Ontario. This next phase will see the installation of a second isotope production system (IPS) at Bruce Power's CANDU Unit 6 reactor, which will allow for a significant increase in the plant's ability to produce the medical isotope lutetium-177, used in targeted cancer therapies. The project is receiving funding through the Canadian Medical Isotope Ecosystem (CMIE), which was established in 2023 with an investment of up to $35 million over five years through the Government of Canada's Strategic Innovation Fund, with the goal of spurring the development and commercialization of medical isotopes and radiopharmaceuticals in Canada. The CMIE directs project funding that supports collaborative research and development initiatives focused on medical isotopes, with the goal of creating and commercializing innovative treatments in the health care sector while also securing the domestic production of medical isotopes. Since March 2020, the government has invested more than $2.5 billion in 43 projects in the biomanufacturing, vaccine and therapeutics ecosystem. The Government of Canada's support for the CMIE is a critical aspect of this investment, bolstering Canada's historical leadership in medical isotope production. The market for medical isotopes worldwide is increasing and is expected to reach up to US$33 billion by 2031. The project expansion announced today helps to ensure that Canada will maintain a steady domestic supply as well as sustain and expand export capabilities to global markets. With its innovative IPS technology, Bruce Power is the first commercial nuclear reactor in the world to produce lutetium-177, supplying large quantities of life-saving medical isotopes while simultaneously generating safe, clean and reliable electricity. This helps advance Canada's role as both an energy and a medical isotope superpower. The Government of Canada is proud to partner with the Saugeen Ojibway Nation (SON) and Bruce Power to produce, advance and market new medical isotopes in support of the global fight against cancer. The project contributes significantly to reconciliation within the SON territory. Quotes "Medical isotopes are a powerful tool in the diagnosis and treatment of cancer. Through the government's investment in the CMIE, as well as its partnership with Bruce Power and the Saugeen Ojibway Nation, we are ensuring that Canadians have access to a critical medical technology. This next phase of Bruce Power's capacity expansion strengthens Canada's role as a global leader in medical isotope production while enhancing the quality of care available to every Canadian." – The Honourable Mélanie Joly, Minister of Industry and Minister responsible for Canada Economic Development for Quebec Regions "Canada is proud to be at the forefront of innovation in both clean energy and life-saving medical technology. By supporting Bruce Power's isotope production system, we are ensuring a stable supply of cancer-fighting isotopes for patients at home and around the world, while creating highly skilled jobs and an attractive investment ecosystem and strengthening Canada's status as a Tier 1 nuclear nation." – The Honourable Tim Hodgson, Minister of Energy and Natural Resources "Canada is proud to support research and development on medical isotopes, which are critical for diagnosing and treating a wide range of diseases, such as cancer and heart disease. With this investment, we will continue to play a leading role in the global supply of medical isotopes and drive the creation of innovative health care treatments for Canadians." – The Honourable Marjorie Michel, Minister of Health "Ontario's nuclear advantage is about powering our economy by harnessing Canadian technology, built by Canadian workers. Almost one-third of Ontario's power is generated at Bruce, and we are also proud to expand the production of life-saving isotopes at this world-class generating station. Ontario has an ambitious plan to double medical isotope production by 2030, driven in part by the expansion at Unit 6, enabling 24/7 production of cancer-fighting isotopes for Canadians and people around the world." – The Honourable Stephen Lecce, Ontario Minister of Energy and Mines "This investment is a crucial step toward meeting Ontario's goal of doubling medical isotope production by 2030. The CMIE is proud to support this initiative and help ensure Canada's medical isotope ecosystem is strong and resilient and remains a global leader in the advancement of cancer care." – Dr. Holly Bilton, Chair of the Canadian Medical Isotope Ecosystem Quick facts The Canadian Medical Isotope Ecosystem (CMIE) is a pan-Canadian initiative led by the Centre for Probe Development and Commercialization and TRIUMF Innovations, not-for-profit corporations specializing in radiopharmaceutical products and the commercialization of particle acceleration, respectively. Supporting the medical isotopes sector through the CMIE will improve Canadian expertise in medical isotopes and make Canada an attractive hub for investment in this sector, contributing to Canada's position as a global leader in the field. Medical isotopes are used by medical professionals to diagnose and treat health conditions such as heart disease and cancer. Medical isotopes are produced using two overarching technologies: nuclear reactors and particle accelerators. There are currently global constraints on the supply of medical isotopes, and the CMIE will ensure that Canada remains at the forefront of nuclear medicine innovation. Lutetium-177 is a medical isotope used in targeted radionuclide therapy for certain cancers, specifically neuroendocrine tumours and prostate cancer. Radionuclide therapies show incredible promise for cancer treatment due to their ability to deliver targeted doses of radiation directly to cancer cells while minimizing potential side effects on healthy cells. By producing these critical resources domestically, Canada will be positioned to take advantage of the ever-growing global market for medical isotopes. Globally, more than 40 million procedures are performed each year using medical isotopes for both diagnostic and therapeutic purposes. Stay connected Find more services and information on the Innovation, Science and Economic Development Canada website. SOURCE Innovation, Science and Economic Development Canada
Globe and Mail
an hour ago
- Globe and Mail
Arkay Beverages and Beyond Spirits Announce Global Expansion of Alcohol-Free Spirits
Miami, Florida--(Newsfile Corp. - August 19, 2025) - Arkay Beverages, a pioneer in the alcohol-free spirits category, together with Beyond Spirits, today announced the expansion of their zero-proof product lines to more than 40 countries worldwide. This milestone reflects the rapid growth in demand for mindful drinking options as consumers increasingly seek alternatives to traditional alcohol. Beyond Spirits Founded in 2011, Arkay Beverages introduced one of the world's first alcohol-free whisky alternatives and has since developed a full portfolio that includes rum, vodka, gin, and tequila substitutes — all alcohol-free, sugar-free, calorie-free, and vegan. Building on this foundation, Beyond Spirits was launched in 2023 to extend the vision with bold, plant-based innovations aimed at a new generation of mindful consumers. Responding to Global Demand Reynald Vito Grattagliano, founder of both brands, stated: "Alcohol has defined socializing for centuries, but it has also created challenges for health and wellbeing. Our mission is to provide a better alternative. Expanding Arkay and Beyond Spirits to more than 40 countries demonstrates the global appetite for healthier, inclusive options in celebrations." Product Highlights Health-Focused: Zero alcohol, zero sugar, zero calories. Inclusive for All: Suitable for athletes, parents-to-be, professionals, and designated drivers. Global Reach: Now distributed across North America, Europe, Asia, and beyond. Accessible Luxury: Premium-quality flavors at approachable price points. Innovation at the Core: Arkay pioneered alcohol-free whisky alternatives; Beyond Spirits introduces plant-based variations and bold new flavors. A Growing Category The alcohol-free spirits sector continues to expand as more consumers adopt mindful drinking habits. Arkay and Beyond Spirits are positioned to serve both traditional cocktail enthusiasts seeking healthier alternatives and younger audiences redefining what it means to "have a drink." About Arkay Beverages Founded in 2011, Arkay Beverages pioneered the alcohol-free spirits category with the introduction of one of the world's first whisky alternatives. Today, Arkay offers a complete range of zero-proof spirits crafted for authenticity, taste, and inclusivity. With a growing international presence, Arkay is at the forefront of the mindful drinking movement. About Beyond Spirits Launched in 2023, Beyond Spirits builds on Arkay's legacy with plant-based innovations that bring fresh flavors and concepts to alcohol-free mixology. The brand is focused on creating products for a new generation of mindful consumers who prioritize wellness and inclusivity.
Globe and Mail
an hour ago
- Globe and Mail
META Focuses on User Safety & Engagement: Ad Revenues to Rise?
Meta Platforms ' META focus on enhancing safety for WhatsApp users and new ways to connect Instagram users is expected to help drive advertising revenues. The company's focus on integrating AI into its platforms — Facebook, WhatsApp, Instagram, Messenger and Threads — is driving user engagement to boost ad revenues. AI push is helping Meta Platforms offer content that is interesting and useful, eventually driving engagement. Improvement in content quality, driven by META's recommendation system, has led to a 5% increase in time spent on Facebook and 6% on Instagram in second-quarter 2025. The launch of AI video editing tools across Meta AI and the new Edits app are noteworthy developments. Meanwhile, META has introduced features and new anti-scam tools in WhatsApp to combat scammers. In the first half of 2025, WhatsApp proactively detected and banned more than 6.8 million accounts tied to online fraud and scams. Safety features now allow WhatsApp users to review details, leave quietly, or mute notifications when a new contact adds the user to an unknown group. For individual WhatsApp chats, Meta Platforms is testing warnings when users message someone outside their contacts. Instagram has launched the latest features and tools like repost, interactive map and Friends tab in Reels. The repost option helps Instagram users share reels and posts, which will appear in friends' feeds and a dedicated repost tab on profiles. The interactive map allows friends to share locations and explore posts, reels and stories tagged to places. The Friends tab in Reels makes it easy to see what content friends are enjoying. In second-quarter 2025, advertising revenues (98.8% of Family of Apps revenues) increased 21.5% year over year to $46.56 billion and accounted for 98% of second-quarter revenues. At constant currency, revenues increased 22% year over year. The Zacks Consensus Estimate for third-quarter 2025 advertising is pegged at $48.07 billion, indicating more than 20% growth over the figure reported in the year-ago quarter. META Faces Tough Competition for Advertising Dollars Meta Platforms is facing tough competition from the likes of Alphabet GOOGL and Amazon AMZN for advertising dollars. Alphabet's advertising revenues rose 10.4% year over year to $71.34 billion and accounted for 74% of second-quarter 2025 total revenues. YouTube's advertising revenues improved 13.1% year over year to $9.77 billion, while Search and other revenues increased 11.7% year over year to $54.19 billion. Alphabet is leveraging AI to boost search dominance with the launch of Gemini 2.5. Search revenues are driven by improving engagement with features like AI Overview, which now has 2 billion users per month and is available in more than 40 languages across 200 countries. Amazon's advertising business reached a milestone in the second quarter of 2025, capturing 9.4% of the company's total revenues — the highest share ever recorded — and rose 23% year over year to $15.69 billion. Amazon's ability to harness its vast retail media presence, proprietary shopping data and expanding connected TV (CTV) footprint is a key catalyst. The global rollout of Prime Video ads adds a high-value, premium channel that may lift revenues. META's Share Price Performance, Valuation & Estimates Meta Platforms' shares have jumped 31% year to date, outperforming the broader Zacks Computer and Technology sector's return of 13.8% and the Zacks Internet Software industry's appreciation of 21.4%. Image Source: Zacks Investment Research Meta Platforms' stock is trading at a premium, with a forward 12-month Price/Sales of 8.98X compared with the broader sector's 6.74X. META has a Value Score of D. META Valuation Image Source: Zacks Investment Research The Zacks Consensus Estimate for 2025 earnings is pegged at $27.98 per share, up 9.8% over the past 30 days, suggesting 17.3% year-over-year growth. Meta Platforms currently carries a Zacks Rank #3 (Hold). You can see the complete list of today's Zacks #1 Rank (Strong Buy) stocks here. See our %%CTA_TEXT%% report – free today! 7 Best Stocks for the Next 30 Days Want the latest recommendations from Zacks Investment Research? Today, you can download 7 Best Stocks for the Next 30 Days. Click to get this free report Inc. (AMZN): Free Stock Analysis Report Alphabet Inc. (GOOGL): Free Stock Analysis Report Meta Platforms, Inc. (META): Free Stock Analysis Report This article originally published on Zacks Investment Research (
